Love Pharma Updates Microdoz Proposed Acquisition with Global Leader in Psychedelic Research

VANCOUVER, BC / ACCESSWIRE / March 3, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0), the Company is pleased to announce updated details on the proposed Microdoz Therapy acquisition (originally announced in a press release …